Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wallace Bourgeois

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cell Reports. Medicine|June 14, 2025
Combined inhibition of KAT6A/B and Menin reverses estrogen receptor-driven gene expression programs in breast cancerSarah Naomi Olsen, Bryn Anderson, Charlie Hatton, et al.
Cell|May 2, 2026
Genetic variation reveals a homeotic long noncoding RNA that modulates human hematopoietic stem cellsPeng Lyu, Gaurav Agarwal, Chun-Jie Guo, et al.
The Journal of Biological Chemistry|June 5, 2014
Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia modelCourtney L Jones, Teena Bhatla, Roy Blum, et al.
Nature Communications|May 8, 2026
CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trialsWallace Bourgeois, Hannah E Rice, Daniela V Wenge, et al.
Blood|December 14, 2023
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AMLWallace Bourgeois, Jevon A Cutler, Brandon J Aubrey, et al.
Nature Cancer|May 9, 2022
IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemiaBrandon J Aubrey, Jevon A Cutler, Wallace Bourgeois, et al.
Blood|September 2, 2015
MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemiaCourtney L Jones, Christy M Gearheart, Susan Fosmire, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemiaShellaina J V Gordon, Florian Perner, Laura MacPherson, et al.
Cancer Discovery|June 19, 2025
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemiaShellaina J V Gordon, Florian Perner, Laura MacPherson, et al.
Leukemia|August 23, 2024
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international communityBranko Cuglievan, Hagop Kantarjian, Jeffrey E Rubnitz, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cell Reports. Medicine|June 14, 2025
Combined inhibition of KAT6A/B and Menin reverses estrogen receptor-driven gene expression programs in breast cancerSarah Naomi Olsen, Bryn Anderson, Charlie Hatton, et al.
Cell|May 2, 2026
Genetic variation reveals a homeotic long noncoding RNA that modulates human hematopoietic stem cellsPeng Lyu, Gaurav Agarwal, Chun-Jie Guo, et al.
The Journal of Biological Chemistry|June 5, 2014
Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia modelCourtney L Jones, Teena Bhatla, Roy Blum, et al.
Nature Communications|May 8, 2026
CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trialsWallace Bourgeois, Hannah E Rice, Daniela V Wenge, et al.
Blood|December 14, 2023
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AMLWallace Bourgeois, Jevon A Cutler, Brandon J Aubrey, et al.
Nature Cancer|May 9, 2022
IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemiaBrandon J Aubrey, Jevon A Cutler, Wallace Bourgeois, et al.
Blood|September 2, 2015
MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemiaCourtney L Jones, Christy M Gearheart, Susan Fosmire, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemiaShellaina J V Gordon, Florian Perner, Laura MacPherson, et al.
Cancer Discovery|June 19, 2025
Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemiaShellaina J V Gordon, Florian Perner, Laura MacPherson, et al.
Leukemia|August 23, 2024
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international communityBranko Cuglievan, Hagop Kantarjian, Jeffrey E Rubnitz, et al.
Pageof 2